BiotechTube

mometasone furoate nasal spray

ApprovedCompleted
0 watching 0 views this week🔥 Hot
80
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Adenoids

Conditions

Adenoids

Trial Timeline

Aug 1, 2008 → Sep 1, 2009

NCT ID
NCT01098071

About mometasone furoate nasal spray

mometasone furoate nasal spray is a approved stage product being developed by Organon for Adenoids. The current trial status is completed. This product is registered under clinical trial identifier NCT01098071. Target conditions include Adenoids.

Hype Score Breakdown

Clinical
30
Activity
20
Company
5
Novelty
10
Community
12

Clinical Trials (2)

NCT IDPhaseStatus
NCT01098071ApprovedCompleted
NCT00491504ApprovedCompleted

Competing Products

1 competing product in Adenoids

See all competitors
ProductCompanyStageHype Score
Mometasone Furoate nasal spray + PlaceboOrganonPhase 3
72

Other Products from Organon

desloratadineApproved
80
tibolone + raloxifenApproved
80
ezetimibe + statinsApproved
80
losartan potassium + Comparator: carvedilol + Comparator: losartan (+) hydrochlorothiazide (HCTZ) + Comparator: carvedilol (+) hydrochlorothiazideApproved
80
Desloratadine 5 mg + fexofenadineApproved
80